Improved Lipid and Lipoprotein Profile, Hepatic Insulin Sensitivity, and Glucose Tolerance in 11β-Hydroxysteroid Dehydrogenase Type 1 Null Mice
Top Cited Papers
Open Access
- 1 November 2001
- journal article
- Published by Elsevier BV
- Vol. 276 (44), 41293-41300
- https://doi.org/10.1074/jbc.m103676200
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- PPARα Agonists Reduce 11β-Hydroxysteroid Dehydrogenase Type 1 in the LiverBiochemical and Biophysical Research Communications, 2000
- Loss of Insulin Signaling in Hepatocytes Leads to Severe Insulin Resistance and Progressive Hepatic DysfunctionMolecular Cell, 2000
- Reduced hepatic fatty acid oxidation in fasting PPARα null mice is due to impaired mitochondrial hydroxymethylglutaryl‐CoA synthase gene expressionFEBS Letters, 2000
- Peroxisome proliferator–activated receptor α mediates the adaptive response to fastingJCI Insight, 1999
- The Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular AnalysisEuropean Journal of Biochemistry, 1997
- Influence of Fibrinogen on Cardiovascular DiseaseDrugs, 1997
- Hypercortisolism and ObesityAnnals of the New York Academy of Sciences, 1995
- Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzymeMolecular and Cellular Endocrinology, 1994
- Feast and Famine: Critical Role of Glucocorticoids with Insulin in Daily Energy FlowFrontiers in Neuroendocrinology, 1993
- Variable effects of different corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoprotein mRNA levels in rats.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991